Showing 211-220 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A Novel Magnetorheological Insulin Pump | Georgia Southern University Research and Service Foundation, Inc | Sevki Cesmeci | Improving Lives | 01-June-2023 to 31-May-2026 | $199.516,50 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-March-2026 | $900.000,00 |
| Treatment of type-1 diabetes with apolipoprotein A4 – efficacy and mechanisms | University of Cincinnati | Min Liu | Cures | 01-March-2023 to 28-February-2026 | $721.291,00 |
| Reducing Diabetes Distress in Adults with Type 1 Diabetes: A pragmatic trial in routine diabetes care. | The Regents of the University of California, San Francisco | Danielle Hessler | Improving Lives | 01-August-2023 to 31-July-2026 | $1.743.010,00 |
| Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-September-2023 to 31-August-2026 | $499.934,12 |
| Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D | Massachusetts General Hospital | Mark Poznansky | Cures | 01-April-2023 to 31-March-2026 | $777.168,00 |
| The master regulator transcription factor, Zbtb20, defines and controls a regulatory T cell subset that controls tissue inflammation. | Rutgers Biomedical and Health Sciences | Derek Sant’Angelo | Cures | 01-March-2023 to 28-February-2027 | $935.026,00 |
| Modulate beta cell proliferation and immunogenicity via aptamer-decorated lipid nanoparticles | University of Miami | Paolo Serafini | Cures | 01-April-2023 to 31-March-2026 | $894.602,00 |
| Multicolor cellular immunoimaging of response to transplanted islet cells | Michigan State University | Bryan Smith | Cures | 01-June-2023 to 31-May-2026 | $750.000,00 |
| Spotlight-AQ 2 Center RCT | Children's Mercy Hospital | Cintya Schweisberger | Improving Lives | 01-September-2023 to 31-August-2026 | $710.434,16 |